Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
about
Lymphatic imaging: focus on imaging probes.Recombinant disintegrin (r-Cam-dis) from Crotalus adamanteus inhibits adhesion of human pancreatic cancer cell lines to laminin-1 and vitronectin.Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy.Triple-phase 99mTc-3P-RGD2 imaging of peripheral primitive neuroectodermal tumor in the hip muscle group with bone metastasis.Iodine-131-labeled, transferrin-capped polypyrrole nanoparticles for tumor-targeted synergistic photothermal-radioisotope therapy.
P2860
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
@en
Anti-tumor effect of integrin targeted
@nl
type
label
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
@en
Anti-tumor effect of integrin targeted
@nl
prefLabel
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
@en
Anti-tumor effect of integrin targeted
@nl
P2093
P2860
P356
P1433
P1476
Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
@en
P2093
Chengyan Dong
Huiyun Zhao
Xiaona Jin
Zhaofei Liu
P2860
P304
P356
10.7150/THNO.7781
P577
2014-01-18T00:00:00Z